| 0 (0%) | 01-19 18:52 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 10.29 |
1-year : | 12.02 |
| Resists | First : | 8.81 |
Second : | 10.29 |
| Pivot price | 7.58 |
|||
| Supports | First : | 7.75 |
Second : | 7.09 |
| MAs | MA(5) : | 7.91 |
MA(20) : | 7.57 |
| MA(100) : | 7.67 |
MA(250) : | 7.89 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 85.4 |
D(3) : | 84.1 |
| RSI | RSI(14): 67.7 |
|||
| 52-week | High : | 9.43 | Low : | 6.25 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ TG ] has closed Bollinger Bands are 15.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 8.83 - 8.86 | 8.86 - 8.89 |
| Low: | 7.96 - 7.99 | 7.99 - 8.03 |
| Close: | 8.24 - 8.3 | 8.3 - 8.36 |
Mon, 19 Jan 2026
TG Metals Extends Van Uden Gold Deposit with New Discovery to the South - TipRanks
Sun, 18 Jan 2026
TG Unit finishes second place at 2026 UDA Nationals - lsureveille.com
Sun, 18 Jan 2026
TG deploys first A321 on BKK-SIN route - TTR Weekly
Fri, 16 Jan 2026
More snow showers to kick off the weekend - WTVQ
Thu, 15 Jan 2026
TG Therapeutics: The 'Exit Velocity' You Can't Ignore (Rating Upgrade) - Seeking Alpha
Wed, 14 Jan 2026
A Look At TG Therapeutics (TGTX) Valuation After New BRIUMVI Revenue Guidance At J.P. Morgan Conference - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 35 (M) |
| Shares Float | 28 (M) |
| Held by Insiders | 23.5 (%) |
| Held by Institutions | 64.3 (%) |
| Shares Short | 377 (K) |
| Shares Short P.Month | 369 (K) |
| EPS | 0.07 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.92 |
| Profit Margin | -7.8 % |
| Operating Margin | 6.4 % |
| Return on Assets (ttm) | 4 % |
| Return on Equity (ttm) | 1.2 % |
| Qtrly Rev. Growth | 33.5 % |
| Gross Profit (p.s.) | 2.93 |
| Sales Per Share | 19.86 |
| EBITDA (p.s.) | 1.4 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 37 (M) |
| Levered Free Cash Flow | 36 (M) |
| PE Ratio | 118.57 |
| PEG Ratio | 0 |
| Price to Book value | 1.39 |
| Price to Sales | 0.41 |
| Price to Cash Flow | 7.86 |
| Dividend | 0.12 |
| Forward Dividend | 0 |
| Dividend Yield | 1.5% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|